DataMEDS AI, Inc. (MEDS)

NASDAQ: MEDS · Real-Time Price · USD

1.480

-0.010 (-0.67%)

At close: Aug 14, 2026, 4:00 PM EDT

1.430

-0.050 (-3.38%)

After-hours: Aug 14, 2026, 7:34 PM EDT

DataMEDS AI Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	14.03	23.34	18.13	-	-
Revenue Growth	-51.59%	28.73%	-	-	-
Gross Profit	-6.95	-6.43	1.77	-	-
Operating Income	-55.86	-81.19	-6.15	-2.88	-0.02
Net Income	-76.59	-101.27	-6.86	-2.9	-0.02
Earnings Per Share	-45.50	-71.33	-7.25	-3.24	-
EPS Growth	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Investments	0.05	0.04	1.03	0	-
Total Debt	28.73	24.58	25	0.35	-
Net Cash (Debt)	-28.68	-24.54	-23.97	-0.35	-
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-17.04	-17.29	-25.36	-0.39	-

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Operating Cash Flow	-12.92	-10.86	-1.22	-0.35	-
Free Cash Flow	-12.92	-10.86	-1.22	-0.35	-
Free Cash Flow Growth	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Gross Margin	-49.51%	-27.54%	9.75%	-	-
Operating Margin	-398.05%	-347.91%	-33.90%	-	-
Pretax Margin	-545.72%	-433.95%	-37.82%	-	-
Profit Margin	-545.72%	-433.95%	-37.82%	-	-

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
PS Ratio	0.26	1.72	-	-	-